Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Brain : a Journal of Neurology
|
March 5, 2020
In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
Gaia Colasante, Yichen Qiu, Luca Massimino, et al.
Science Advances
|
April 20, 2019
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
Mikail Weston, Teresa Kaserer, Angela Wu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 26, 2013
Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1
Susan Elizabeth Tomlinson, Sanjeev Rajakulendran, Stella Veronica Tan, et al.
Molecular Therapy. Nucleic Acids
|
May 25, 2026
AAV9-mediated targeting of natural antisense transcript as a novel treatment for Dravet syndrome
Juan Antinao Diaz, Ellie M Chilcott, Amanda Almacellas Barbanoj, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 14, 2019
Epilepsy Gene Therapy Using an Engineered Potassium Channel
Albert Snowball, Elodie Chabrol, Robert C Wykes, et al.
Epilepsia
|
January 15, 2014
A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation study
Katja Menzler, Anke Hermsen, Katharina Balkenhol, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 15, 2019
dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice
Gaia Colasante, Gabriele Lignani, Simone Brusco, et al.
Molecular Therapy. Nucleic Acids
|
March 23, 2017
Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy
Cristina R Reschke, Luiz F Almeida Silva, Braxton A Norwood, et al.
Science (New York, N.Y.)
|
November 15, 2022
On-demand cell-autonomous gene therapy for brain circuit disorders
Yichen Qiu, Nathanael O'Neill, Benito Maffei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 12, 2018
Spider toxin inhibits gating pore currents underlying periodic paralysis
Roope Männikkö, Zakhar O Shenkarev, Michael G Thor, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Brain : a Journal of Neurology
|
March 5, 2020
In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
Gaia Colasante, Yichen Qiu, Luca Massimino, et al.
Science Advances
|
April 20, 2019
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
Mikail Weston, Teresa Kaserer, Angela Wu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 26, 2013
Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1
Susan Elizabeth Tomlinson, Sanjeev Rajakulendran, Stella Veronica Tan, et al.
Molecular Therapy. Nucleic Acids
|
May 25, 2026
AAV9-mediated targeting of natural antisense transcript as a novel treatment for Dravet syndrome
Juan Antinao Diaz, Ellie M Chilcott, Amanda Almacellas Barbanoj, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 14, 2019
Epilepsy Gene Therapy Using an Engineered Potassium Channel
Albert Snowball, Elodie Chabrol, Robert C Wykes, et al.
Epilepsia
|
January 15, 2014
A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation study
Katja Menzler, Anke Hermsen, Katharina Balkenhol, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 15, 2019
dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice
Gaia Colasante, Gabriele Lignani, Simone Brusco, et al.
Molecular Therapy. Nucleic Acids
|
March 23, 2017
Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy
Cristina R Reschke, Luiz F Almeida Silva, Braxton A Norwood, et al.
Science (New York, N.Y.)
|
November 15, 2022
On-demand cell-autonomous gene therapy for brain circuit disorders
Yichen Qiu, Nathanael O'Neill, Benito Maffei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 12, 2018
Spider toxin inhibits gating pore currents underlying periodic paralysis
Roope Männikkö, Zakhar O Shenkarev, Michael G Thor, et al.
Page
of 7